Akeso Inc

Health Care

44.35 ₽

Current price

Sell

44.35 ₽

Target price 00%

Ranks rating

76

Position in sub-industry

356 / 1361
Position in country

4529 / 7387

Return on Assets, %

28.3

-40.3
Net income margin, %

-64.5

-180
EBITDA margin, %

-55.7

-168.2
Debt to Equity, %

63.7

3.2
Intangible assets and goodwill, %

0

0.2

Revenue Y, % chg

413

0

P/E

18.8

31
P/BV

8.1

1.8
P/S

8.7

10.3
EV/S

8.8

7.5
EV/EBITDA

19.8

-1.6

Average Analyst recommendation

Buy

Buy
Average upside forecasts, %

21.4

131.1

Expected dividend per share

0

0
Payout Ratio, %

0

0

Get an analytical review of this company

Competitors

Ranks

Imeik Technology Development Co Ltd

00%
Chongqing Zhifei Biological Products Co Ltd

00%
Shanghai RAAS Blood Products Co Ltd

00%
Hualan Biological Engineering Inc

00%
Beijing Tiantan Biological Products Corp Ltd

00%
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

00%
Akeso Inc

00%
Gan & Lee Pharmaceuticals

00%
Innovent Biologics Inc

00%
Beijing Wantai Biological Pharmacy Enterprise Co Ltd

00%

Ready-made portfolio of the best Russian stocks

Created by artificial intelligence
Verified by analysts
Available even to beginners

Company information

Country

China
Sector

Health Care
Industry group

Pharmaceuticals, Biotechnology & Life Sciences
Industry

Biotechnology
Sub-sector

Health Care
Capitalization (millions of $)

5468.2
Ticker

9926.HK
ISIN

KYG0146B1032
IPO date

2020-04-24
Availability on Russian exchanges

No
Reporting for

2024-03-18
Date fact. publication of reports

2023-12-31

Company Description